Phio Pharmaceuticals Announces Publication In Frontiers In Immunology Announces Its Manuscript, Self-Delivering RNAi Immunotherapeutic PH-762 Silences PD-1 To Generate Local And Abscopal Anti-Tumor Efficacy, Has Been Published In The December, 2024...

BenzingaDec 12 09:32 ET

Phio Pharmaceuticals Completes Enrollment In Second Cohort In Phase 1b Dose-Escalating Clinical Study

BenzingaNov 19 07:48 ET

Phio Pharmaceuticals Announces Completion of Enrollment in Second Cohort in Phase 1b Dose-Escalating Clinical Study

newsfileNov 19 07:45 ET

Phio Pharma Shares Are Trading Higher. The Company Reported Q3 Financial Results.

BenzingaNov 15 08:36 ET

Express News | Phio Pharma Shares Are Trading Higher. The Company Reported Q3 Financial Results

BenzingaNov 15 08:36 ET

Phio Pharma Q3 2024 GAAP EPS $(1.54) May Not Be Comparable To $(4.14) Estimate

BenzingaNov 14 17:50 ET